astressin



astressin

F1FF1H2HH2L3LL3L4LL4R5RR5E6EE6V7VV7L8LL8E9EE9X10XX10A11AA11R12RR12A13AA13E14EE14Q15QQ15L16LL16A17AA17Q18QQ18E19EE19A20AA20H21HH21K22KK22N23NN23R24RR24K25KK25L26LL26X27XX27E28EE28I29II29I30II30

SMILES None
InChIKey HPYIIXJJVYSMCV-MGDXKYBTSA-N
Sequence FHLLREVLEXARAEQLAQEAHKNRKLXEII

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections

Ligand site mutations CRF1 CRF2

Bioactivities

astressin

F1FF1H2HH2L3LL3L4LL4R5RR5E6EE6V7VV7L8LL8E9EE9X10XX10A11AA11R12RR12A13AA13E14EE14Q15QQ15L16LL16A17AA17Q18QQ18E19EE19A20AA20H21HH21K22KK22N23NN23R24RR24K25KK25L26LL26X27XX27E28EE28I29II29I30II30

Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Ligand site mutations CRF1 CRF2

Compound is not listed as a drug.